Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump‐treated type 1 diabetes

利拉鲁肽 超重 医学 安慰剂 内科学 内分泌学 胰岛素 肥胖 1型糖尿病 2型糖尿病 糖尿病 瘦体质量 置信区间 减肥 体重 替代医学 病理
作者
Signe Schmidt,Christian S. Frandsen,Thomas F. Dejgaard,Dorte Vistisen,Þórhallur I. Halldórsson,Sjúrður F. Olsen,Jens‐Erik Beck Jensen,Sten Madsbad,Henrik U. Andersen,Kirsten Nørgaard
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:24 (2): 212-220 被引量:12
标识
DOI:10.1111/dom.14567
摘要

Abstract Aims To present secondary outcome analyses of liraglutide treatment in overweight adults with insulin pump‐treated type 1 diabetes (T1D), focusing on changes in body composition and dimensions, and to evaluate changes in food intake to identify potential dietary drivers of liraglutide‐associated weight loss. Materials and methods A 26‐week randomized placebo‐controlled study was conducted to investigate the efficacy and safety of liraglutide 1.8 mg daily in 44 overweight adults with insulin pump‐treated T1D and glucose levels above target, and demonstrated significant glycated haemoglobin (HbA1c)‐ and body weight‐reducing effects. For secondary outcome analysis, dual X‐ray absorptiometry scans were completed at Weeks 0 and 26, and questionnaire‐based food frequency recordings were obtained at Weeks 0, 13 and 26 to characterize liraglutide‐induced changes in body composition and food intake. Results Total fat and lean body mass decreased in liraglutide‐treated participants (fat mass −4.6 kg [95% confidence interval {CI} −5.7; −3.5], P < 0.001; lean mass −2.5 kg [95% CI −3.2;‐1.7], P < 0.001), but remained stable in placebo‐treated participants (fat mass −0.3 kg [95% CI −1.3;0.8], P = 0.604; lean mass 0.0 kg [95% CI −0.7;0.7]; P = 0.965 [between‐group P values <0.001]). Participants reduced their energy intake numerically more in the liraglutide arm (−1.1 MJ [95% CI −2.0;‐0.02], P = 0.02) than in the placebo arm (−0.9 MJ [95% CI −2.0;0.1], P = 0.22), but the between‐group difference was statistically insignificant ( P = 0.42). However, energy derived from added sugars decreased by 27% in the liraglutide arm compared with an increase of 14% in the placebo arm ( P = 0.004). Conclusions Liraglutide lowered fat and lean body mass compared with placebo. Further, liraglutide reduced intake of added sugars. However, no significant difference in total daily energy intake was detected between liraglutide‐ and placebo‐treated participants.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
cindywu发布了新的文献求助10
2秒前
科研通AI2S应助Huang_being采纳,获得10
2秒前
2秒前
3秒前
量子星尘发布了新的文献求助10
3秒前
HCB1发布了新的文献求助10
4秒前
4秒前
ShuXU完成签到,获得积分10
6秒前
6秒前
Pom完成签到,获得积分10
6秒前
gujiguji发布了新的文献求助10
8秒前
科研通AI2S应助HCB1采纳,获得10
8秒前
HOME发布了新的文献求助30
9秒前
阿俊发布了新的文献求助10
9秒前
11秒前
Richard发布了新的文献求助10
11秒前
FashionBoy应助sanyecai采纳,获得10
14秒前
14秒前
15秒前
科目三应助gujiguji采纳,获得10
15秒前
advance发布了新的文献求助10
17秒前
18秒前
18秒前
小二郎应助科研通管家采纳,获得10
18秒前
在水一方应助科研通管家采纳,获得10
18秒前
丘比特应助科研通管家采纳,获得10
18秒前
朱建军应助科研通管家采纳,获得30
19秒前
李健应助科研通管家采纳,获得10
19秒前
科目三应助anan采纳,获得30
19秒前
所所应助科研通管家采纳,获得10
19秒前
酷波er应助科研通管家采纳,获得10
19秒前
英姑应助科研通管家采纳,获得10
19秒前
慕青应助科研通管家采纳,获得10
19秒前
大个应助科研通管家采纳,获得30
19秒前
19秒前
20秒前
漠阳发布了新的文献求助10
20秒前
21秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988920
求助须知:如何正确求助?哪些是违规求助? 3531290
关于积分的说明 11253247
捐赠科研通 3269903
什么是DOI,文献DOI怎么找? 1804830
邀请新用户注册赠送积分活动 882027
科研通“疑难数据库(出版商)”最低求助积分说明 809052